Canagliflozin heart failure with preserved ejection fraction study in type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2018
At a glance
- Drugs Canagliflozin (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms CANONICAL Study
- 05 Dec 2018 Planned End Date changed from 30 Sep 2019 to 31 Dec 2019.
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.
- 04 Oct 2017 New trial record